Back to search

Sweden· SE-19640224000028

Intralipid 100 mg/ml Infusionsvätska, emulsion

A medicinal product containing soya oil + purified, registered in Sweden by Fresenius Kabi AB.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedIntralipid 100 mg/ml Infusionsvätska,…ATC—REGISTER NO.SE-19640224000028PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Soya Oil + Purified
Manufacturer
Fresenius Kabi AB
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    19640224000028

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b34abbb7-e4b3-49bf-9776-2ffc6ba76f2a
GET /v1/drugs/b34abbb7-e4b3-49bf-9776-2ffc6ba76f2a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC"
  ],
  "se_npl_id": "19640224000028",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19640224000028",
  "product_doc_link": "https://docetp.mpa.se/LMF/Intralipid%20100%20mg%20per%20ml%20emulsion%20for%20infusion%20SmPC_09001bee807a4993.pdf"
}

See everything about soya oil + purified.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.